Physician profile
Lajos Toth
NPI 1306816467
$1,316.51
in general payments reported to CMS, 2019-2025
20 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $42.87 · 2021: $60.37 · 2022: $239 · 2023: $263 · 2024: $339 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $251.19 | 2019-2024 | Airsupra |
| Glaxosmithkline, LLC. | $228.57 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $205.54 | 2019-2023 | Rybelsus, Ozempic |
| Abbvie INC. | $102.05 | 2020-2023 | Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $98.91 | 2023 | |
| Astellas Pharma US INC | $97.35 | 2023-2024 | Veozah |
| Inspire Medical Systems, INC. | $63.97 | 2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $49.67 | 2024 | Rexulti |
| Pfizer INC. | $37.82 | 2019-2025 | |
| Abbott Laboratories | $26.35 | 2020-2023 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $22.79 | 2024 | Auvelity |
| Boston Scientific Corporation | $16.94 | 2025 | General - Pain Management |
| Dexcom, INC. | $16.64 | 2024 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.01 | 2020 | |
| Ironwood Pharmaceuticals, INC | $15.26 | 2023 | Linzess |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $14.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.82 | 2019 | |
| Reprise Biomedical, INC. | $13.09 | 2025 | Miro 3d |
| Genentech USA, INC. | $12.91 | 2019 | |
| Lilly USA, LLC | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lajos Toth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.